These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11913202)

  • 1. Pregnancy termination. Understanding and supporting women who undergo medical abortion.
    Goss GL
    AWHONN Lifelines; 2002; 6(1):46-50. PubMed ID: 11913202
    [No Abstract]   [Full Text] [Related]  

  • 2. Care of women having termination of first-trimester pregnancy.
    Murphy F; Jordan S; Jones L
    Br J Nurs; 2000 Nov 23-Dec 7; 9(21):2235-41. PubMed ID: 12271175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
    Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B
    Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical abortion for first-trimester termination of the pregnancy].
    Nikolov A; Atanasova M
    Akush Ginekol (Sofiia); 2013; 52(6):61-4. PubMed ID: 24505631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study.
    Henshaw R; Naji S; Russell I; Templeton A
    Acta Obstet Gynecol Scand; 1994 Nov; 73(10):812-8. PubMed ID: 7817735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Professional development. Termination of pregnancy: knowledge for practice (continuing education credit).
    White B
    Nurs Times; 1996 Apr 3-9; 92(14):suppl 1-4. PubMed ID: 8700696
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
    Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of acceptability of RU486 and ONO 802 in a Chinese population.
    Tang GW
    Contraception; 1991 Nov; 44(5):523-32. PubMed ID: 1797467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of medical and surgical termination of pregnancy: choice, emotional impact and satisfaction with care.
    Slade P; Heke S; Fletcher J; Stewart P
    Br J Obstet Gynaecol; 1998 Dec; 105(12):1288-95. PubMed ID: 9883920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological distress symptoms in women undergoing medical vs. surgical termination of pregnancy.
    Lowenstein L; Deutcsh M; Gruberg R; Solt I; Yagil Y; Nevo O; Bloch M
    Gen Hosp Psychiatry; 2006; 28(1):43-7. PubMed ID: 16377364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy interruption using mifepristone (RU-486). A new choice for women in the USA.
    Mackenzie SJ; Yeo S
    J Nurse Midwifery; 1997; 42(2):86-90. PubMed ID: 9107115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiences.
    Fielding SL; Edmunds E; Schaff EA
    Perspect Sex Reprod Health; 2002; 34(1):34-40. PubMed ID: 11990637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
    Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
    Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability of medical abortion in early pregnancy.
    Winikoff B
    Fam Plann Perspect; 1995; 27(4):142-8, 185. PubMed ID: 7589354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of second-trimester pregnancy by mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate (Rivanol®): a systematic review of Chinese trials.
    Hou SP; Fang AH; Chen QF; Huang YM; Chen OJ; Cheng LN
    Contraception; 2011 Sep; 84(3):214-23. PubMed ID: 21843683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of placental protein 14 and progesterone following Mifepristone (RU38486) and Gemeprost for termination of first trimester pregnancy.
    Howell RJ; Olajide F; Teisner B; Grudzinskas G; Chard T
    Fertil Steril; 1989 Jul; 52(1):66-8. PubMed ID: 2744189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical termination of pregnancy by mifepristone and misoprostol - evaluation of succes rate, complications and satisfaction of patients].
    Frank K; Gerychová R; Janků P; Huser M; Ventruba P
    Ceska Gynekol; 2015 Dec; 80(6):451-5. PubMed ID: 26741161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost.
    Bartley J; Tong S; Everington D; Baird DT
    Contraception; 2000 Dec; 62(6):297-303. PubMed ID: 11239616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.